Serum Lipoprotein(a) Level and Clinical Coronary Stenosis Progression in Patients With Myocardial Infarction Re-Revascularization Rate is High in Patients With High-Lp(a)

書誌事項

タイトル別名
  • Re-Revascularization Rate is High in Patients With High-Lp(a)

この論文をさがす

説明

Background High serum lipoprotein(a) (Lp(a)) levels are associated with coronary artery disease. Methods and Results The serum Lp(a) levels of 130 patients with acute myocardial infarction (AMI) who underwent direct percutaneous coronary intervention were investigated. On the basis of Lp(a) level at 1 month after the onset of AMI, the patients were classified into 2 groups (high-Lp(a) (≥30 mg/dl) and low-Lp(a) (<30 mg/dl)) for evaluation of the clinical coronary stenosis progression (CCSP) rate. CCSP is defined as either target lesion revascularization (TLR) or new lesion revascularization (NLR). The CCSP rate was significantly higher in the high-Lp(a) group than in the low-Lp(a) group (65.8% vs 29.3%, p<0.01). In patients who had coronary stents in the acute phase (n=79), the CCSP and NLR rates were significantly higher in the high-Lp(a) group than in the low-Lp(a) group (45.0% vs 20.3%, p<0.05; 35.0% vs 6.8%, p<0.01), but there was no significant difference in TLR rate between the 2 groups (10.0% vs 13.6%, p=0.858). Conclusions High serum Lp(a) level is a significant risk factor for CCSP, but does not influence restenosis after stenting. (Circ J 2006; 70: 156 - 162)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 70 (2), 156-162, 2006

    一般社団法人 日本循環器学会

被引用文献 (1)*注記

もっと見る

参考文献 (46)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ